Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Choroidal Neovascularization, Age-related Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01948830
What this trial is testing

Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Novartis Pharmaceuticals 650
Large-scale testing (Phase 3)Study completedNCT02434328
What this trial is testing

Efficacy and Safety of RTH258 Versus Aflibercept - Study 2

Who this might be right for
Neovascular Age-Related Macular DegenerationChoroidal Neovascularization
Alcon Research 1,048
Not applicableWithdrawnNCT01336907
What this trial is testing

Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Notal Vision Ltd.
Post-approval studies (Phase 4)Not Yet RecruitingNCT07187804
What this trial is testing

Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization

Who this might be right for
Age-related Macular Degeneration (ARMD)Choroidal NeovascularizationAnti-vascular Endothelial Growth Factor
Kim's Eye Hospital 30
Large-scale testing (Phase 3)Study completedNCT00251459
What this trial is testing

Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-related Macular Degeneration
Genentech, Inc. 5,000
Testing effectiveness (Phase 2)Study completedNCT00359164
What this trial is testing

Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab.

Who this might be right for
Macular Degeneration
University of British Columbia 36
Post-approval studies (Phase 4)Study completedNCT01950741
What this trial is testing

Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy

Who this might be right for
Exudative Age-related Macular DegenerationPolypoidal Choroidal Vasculopathy
Pusan National University Hospital 48
Testing effectiveness (Phase 2)Ended earlyNCT00766337
What this trial is testing

Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
Santen Inc. 62
Not applicableStudy completedNCT00801541
What this trial is testing

Characterization of Early Markers of Choroidal Neovascularization

Who this might be right for
Age-related Macular Degeneration
Association for Innovation and Biomedical Research on Light and Image 60
Large-scale testing (Phase 3)Ended earlyNCT04049266
What this trial is testing

Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.

Who this might be right for
Wet Macular Degeneration
Kodiak Sciences Inc 559
Not applicableStudy completedNCT00884637
What this trial is testing

Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT00426998
What this trial is testing

Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
Retinal Consultants Medical Group 30
Not applicableStudy completedNCT00808197
What this trial is testing

Choroidal Blood Flow and Progression of Age-Related Macular Degeneration in the Fellow Eye in Patients With Unilateral Choroidal Neovascularisation

Who this might be right for
Regional Blood Flow
Medical University of Vienna 41
Post-approval studies (Phase 4)Study completedNCT03409250
What this trial is testing

SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia

Who this might be right for
Choroidal NeovascularizationAge Related Macular Degeneration
Vista Klinik 20
Not applicableStudy completedNCT05969418
What this trial is testing

Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC

Who this might be right for
Macular Degeneration Choroidal Neovascularization
Federico II University 50
Post-approval studies (Phase 4)Ended earlyNCT05473715
What this trial is testing

Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Bayer 3
Early research (Phase 1)Study completedNCT00101764
What this trial is testing

Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders

Who this might be right for
Macular DegenerationRetinal Vein OcclusionDiabetic Retinopathy
National Eye Institute (NEI) 120
Testing effectiveness (Phase 2)Ended earlyNCT02387957
What this trial is testing

A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 63
Large-scale testing (Phase 3)Study completedNCT00150202
What this trial is testing

Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)

Who this might be right for
Macular Degeneration
Pfizer 90
Not applicableStudy completedNCT00359008
What this trial is testing

PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 336
Next Page